CASTAGNOLI, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 5.197
AS - Asia 3.667
EU - Europa 2.251
SA - Sud America 800
AF - Africa 149
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.082
Nazione #
US - Stati Uniti d'America 5.020
CN - Cina 1.118
SG - Singapore 1.061
BR - Brasile 614
IE - Irlanda 598
HK - Hong Kong 573
VN - Vietnam 385
RU - Federazione Russa 356
DE - Germania 273
FR - Francia 192
IT - Italia 181
FI - Finlandia 168
IN - India 150
GB - Regno Unito 120
CA - Canada 101
SE - Svezia 89
AR - Argentina 78
BD - Bangladesh 72
UA - Ucraina 61
ZA - Sudafrica 60
PL - Polonia 45
MX - Messico 44
NL - Olanda 40
IQ - Iraq 37
PK - Pakistan 36
JP - Giappone 33
AT - Austria 30
ES - Italia 30
TR - Turchia 27
ID - Indonesia 26
CO - Colombia 25
EC - Ecuador 25
PH - Filippine 22
MA - Marocco 17
UZ - Uzbekistan 16
BE - Belgio 15
VE - Venezuela 15
EG - Egitto 13
SA - Arabia Saudita 13
TN - Tunisia 13
IL - Israele 12
KE - Kenya 12
AU - Australia 11
MY - Malesia 10
PY - Paraguay 10
AZ - Azerbaigian 9
LT - Lituania 9
CL - Cile 8
GR - Grecia 8
MU - Mauritius 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
CH - Svizzera 7
CR - Costa Rica 7
DZ - Algeria 6
JO - Giordania 6
UY - Uruguay 6
GE - Georgia 5
JM - Giamaica 5
KG - Kirghizistan 5
KR - Corea 5
LV - Lettonia 5
OM - Oman 5
PA - Panama 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
EU - Europa 4
KZ - Kazakistan 4
LB - Libano 4
NP - Nepal 4
TH - Thailandia 4
AM - Armenia 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
GY - Guiana 3
HN - Honduras 3
IR - Iran 3
PS - Palestinian Territory 3
AO - Angola 2
BW - Botswana 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
GP - Guadalupe 2
HR - Croazia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
NI - Nicaragua 2
PT - Portogallo 2
RO - Romania 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
Totale 12.063
Città #
San Jose 680
Dublin 592
Singapore 568
Ashburn 565
Hong Kong 564
Dallas 495
Chandler 492
Beijing 310
Boardman 175
Lauterbourg 159
Ho Chi Minh City 151
Los Angeles 143
Princeton 124
Lawrence 120
New York 107
Council Bluffs 106
Medford 105
Helsinki 102
Jacksonville 98
Munich 88
Nanjing 86
Hanoi 84
Redondo Beach 84
Wilmington 75
Buffalo 66
Shanghai 61
São Paulo 61
Moscow 54
Ann Arbor 50
Toronto 45
Johannesburg 44
Chicago 41
Seattle 41
Nuremberg 39
The Dalles 38
Warsaw 38
Turku 36
Changsha 35
Nanchang 34
Orem 34
Santa Clara 33
Frankfurt am Main 32
Tokyo 30
Chennai 28
Milan 28
Brooklyn 27
Shenyang 27
Atlanta 26
Denver 26
Rio de Janeiro 26
Hangzhou 25
Montreal 25
Washington 25
Jiaxing 22
San Francisco 22
Tianjin 21
Da Nang 20
Hebei 20
London 18
Fairfield 17
Haiphong 17
Phoenix 17
Columbus 16
Falkenstein 16
Stockholm 16
Brussels 15
Dhaka 15
Houston 15
Mexico City 15
Belo Horizonte 14
Boston 14
Brasília 14
Pavia 14
Pune 14
Tashkent 14
Baghdad 13
Des Moines 13
Manchester 13
Mumbai 13
Amsterdam 12
Guangzhou 12
Hyderabad 12
Poplar 12
Woodbridge 12
Nairobi 11
Norwalk 11
Redwood City 11
Guayaquil 10
Memphis 10
New Delhi 10
Paris 10
Vienna 10
Zhengzhou 10
Jinan 9
Rome 9
Baku 8
Biên Hòa 8
Jakarta 8
Bogotá 7
Cairo 7
Totale 7.775
Nome #
A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: A three-center, assessor blinded trial 176
Impact of passive smoke and/or atopy on adenoid immunoglobulin production in children 160
Clinical features of pediatric chronic urticaria: A single-center analysis 153
Allergy work-up in a child undergoing general anesthesia, with suspected latex allergy 128
Asthma endotyping and biomarkers in childhood asthma 127
ATOPIC DERMATITIS: IS THERE A ROLE FOR PROBIOTICS? 125
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 125
Allergic reaction to oral Furosemide 121
An update on biological therapies for pediatric allergic diseases 120
An immune-based biomarker signature is associated with mortality in COVID-19 patients. 118
Amiodarone hypersensitivity reaction and basophil activation test 118
X-Linked Hypohidrotic Ectodermal Dysplasia: New Features and a Novel EDA Gene Mutation 117
From IgE to clinical trials of allergic rhinitis 116
Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares 115
Allergen immunotherapy for IgE-mediated food allergy: There is a measure in everything to a proper proportion of therapy 115
Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis 113
Allergy and covid-19 113
The role of upper airway pathology as a co-morbidity in severe asthma 108
Clinical and Epidemiological Features of Pediatric Patients with COVID-19 in a Tertiary Pediatric Hospital 107
Biologic Use in Allergic and Asthmatic Children and Adolescents during the COVID-19 Pandemic 107
Allergen immunotherapy in children and adolescents with respiratory diseases 106
Additional Concerns Regarding Children With Coronavirus Disease 2019-Reply 106
Omalizumab for the treatment of chronic idiopathic/spontaneous urticaria in children 104
Novel Approaches to the Study of Neonatal Infections 104
An update on anti-ige therapy in pediatric respiratory diseases 103
Selective IgM Deficiency: Evidence, Controversies, and Gaps 102
Eosinophilic gastrointestinal disorders in children: An Italian single-center experience 102
Immunomodulation in pediatric asthma 100
Current recommendations and emerging options for the treatment of allergic rhinitis. 99
Egg allergy: diagnosis and benefit of basophilic activation test 97
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic 97
Behavioral issues and quality of life in children with eosinophilic esophagitis 97
An asymptomatic mediastinal cyst in a young child: Case report and summary of the literature 95
COVID-19 in the pediatric population admitted to a tertiary referral hospital in Northern Italy: Preliminary clinical data 95
Mitochondrial Complex I Deficiency: Unraveling the Relevance of NDUFAF1 in Pediatric Hypertrophic Cardiomyopathy 93
Clinical and immunological phenotypes of selective IgM deficiency in children: Results from a multicenter study 93
SARS-CoV-2 infection in pediatric population 93
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19 93
Association between treatment awareness and uncontrolled asthma in adolescents 92
Omalizumab in children. 92
Timely adaptation of a pediatric unit to COVID-19 emergency in Northern Italy: The experience of Fondazione IRCCS Policlinico San Matteo in Pavia 92
A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak 91
Predicting challenge outcomes in children: role of histamine levels 91
Biomarkers of immunotherapy response in patients with allergic rhinitis 91
Off-label treatment with Cyclosporine A in a child with severe atopic dermatitis 91
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma 90
Alpha-Gal Syndrome in Children: Peculiarities of a “Tick-Borne” Allergic Disease 90
COVID-19 and autoimmune diseases: is there a connection? 89
Novel biologics for the treatment of pediatric severe asthma 88
Protocols for drug allergy desensitization in children 87
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents 85
Admission rates for respiratory diseases during the covid-19 pandemic: The experience of the pediatric clinic in Pavia 83
Clinical Heterogeneity of Early-Onset Autoimmune Gastritis: From the Evidence to a Pediatric Tailored Algorithm 82
Hymenoptera venom allergy among children in Italy: time for pediatricians to take action 81
Eosinophilic Gastrointestinal Diseases in Inborn Errors of Immunity 79
Food allergies: Current and future treatments 79
Towards precision medicine in pediatric severe asthma: An update on current and emerging biomarkers 78
Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 78
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 76
Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C 76
Omalizumab in children with severe allergic asthma: The Italian real- life experience 75
Quantitation of T Cell Repertoire Diversity Following Treatment for SCID 75
Skin tests are important in children with β-lactam hypersensitivity, but may be reduced in number 74
Personalized therapies for the treatment of allergic rhinitis 72
Inborn errors of immunity with atopic phenotypes in the allergy and immunology clinic: a practical review 72
Low T-Cell Receptor beta (TRB) Repertoire Diversity Early Post-Transplant for Severe Combined Immunodeficiency (SCID) Predicts Subsequent Failure of Immune Reconstitution 71
Pediatric COVID-19 – a review 71
Pediatric COVID-19 – a review 70
Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population 70
Type-2 inflammatory mediators as targets for precision medicine in children 70
Characterization of Gut Inflammation and Autoimmunity in Mice Carrying Rag1 Hypomorphic Mutations 69
Severe uncontrolled asthma in children: Practical approach on diagnosis and management 68
NGS Reveals Repertoire Restriction of Treg Cells in APDS1 Patients 68
Immunological basis of virus-host interaction in COVID-19 68
Activated phosphoinositide 3-dinase delta syndrome (APDS): An update 68
Drug allergy: epidemiology of a cohort of pediatric patient 67
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review 67
Hymenoptera venom allergy in children 66
The use of basophil activation test to diagnose egg-allergy in children 66
Complete Absence of CD3γ Protein Expression Is Responsible for Combined Immunodeficiency with Autoimmunity Rather than SCID 66
Human inborn errors of immunity caused by defects of receptor and proteins of cellular membrane 64
Urticaria in childhood 63
CAR-T Cell Therapy in Autoimmune Setting: A New Appealing Approach Extendable to Allergy? 62
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection 62
The discovery and development of omalizumab for the treatment of asthma 62
Anxiety and depression in adolescents with asthma: a study in clinical practice 62
Emerging drugs for the treatment of perennial allergic rhinitis 61
Low T-Cell Receptor β ( ) Repertoire Diversity Early Post-Transplant for Severe Combined Immunodeficiency (SCID) Predicts Subsequent Failure of Immune Reconstitution 61
Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices 60
Updates on new monogenic inborn errors of immunity 60
Eosinophilic esophagitis after congenital diaphragmatic hernia 59
Development of a peptide conjugate vaccine for inducing therapeutic anti-IgE antibodies 59
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives 59
Identification of gut inflammation and autoimmunity in murine models carrying Rag1 hypomorphic mutations 59
Inborn Errors of Immunity With Immune Dysregulation: From Bench to Bedside 59
Epidemiology of rare allergic diseases in children 59
New approaches for identifying and testing potential new anti-asthma agents 58
Applying the new guidelines to asthma management in children 58
Monoclonal antibodies in pediatric allergy 57
Low T-cell receptor beta (TRB) Repertoire Diversity Early Post-transplant for Severe Combined Immunodeficiency SCID Predicts Subsequent Failure of Immune Reconstitution 57
Totale 8.736
Categoria #
all - tutte 61.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022616 13 2 30 3 17 44 4 15 33 96 75 284
2022/20231.529 176 104 32 107 95 152 1 84 696 6 59 17
2023/2024776 76 140 52 45 64 192 48 44 6 51 38 20
2024/20252.478 36 185 57 64 49 91 220 120 577 121 351 607
2025/20266.081 517 459 729 673 765 254 1.127 240 503 359 299 156
Totale 12.311